Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TBK1-binding protein 1 (TBKBP1) is a cytosolic adaptor protein that serves as a scaffold to recruit and coordinate signaling molecules, particularly the kinase TBK1, in pathways central to innate immunity and signal transduction[3]. TBKBP1 participates in the TNF/NF-κB pathway by linking TBK1 to various substrates and regulatory complexes, impacting processes such as interferon signaling, cellular stress response, and autophagy. As an adaptor, TBKBP1 does not possess enzymatic activity itself but is required for proper localization and activation of its binding partners. Disruption of TBKBP1 has implications in immune dysfunction, neurodegeneration, and cancer, especially in settings where TBK1 pathway modulation is critical for disease progression or therapy resistance[3].
No direct drug mechanism established; potential targeting is via modulation of TBK1 activity through disrupting adaptor scaffold function
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TBK1-binding protein 1 (TBKBP1).